Instrument development of the UNC dry eye management scale

Cornea

Volumn 33, Issue 11, 2014, Pages 1186-1192

  Grubbs, Joseph ^a,b,d   Huynh, Kyle ^a,c   Tolleson Rinehart, Sue ^a,b   Weaver, Mark A ^a   Williamson, Jennifer ^a   Lefebvre, Chelsea ^a   Davis, Richard M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d NONE   (United States)

Author keywords

Dry eye disease; Instrument development; Quality of life measures; Validity and reliability testing

Indexed keywords

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL ARTICLE; COGNITION ASSESSMENT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITERION RELATED VALIDITY; DRY EYE; FEEDBACK SYSTEM; FEMALE; GOLD STANDARD; HUMAN; MALE; OCULAR SURFACE DISEASE INDEX; PRIORITY JOURNAL; QUALITY OF LIFE; TEST RETEST RELIABILITY; UNIVERSITY OF NORTH CAROLINA DRY EYE MANAGEMENT SCALE; DRY EYE SYNDROMES; MIDDLE AGED; OPHTHALMOLOGY; PSYCHOLOGY; QUESTIONNAIRE; REPRODUCIBILITY; SICKNESS IMPACT PROFILE; UNITED STATES; UNIVERSITY HOSPITAL; VALIDATION STUDY;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; DRY EYE SYNDROMES; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; OPHTHALMOLOGY; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE;

EID: 84926101638     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000243     Document Type: Article

References (23)

1. Miljanović B, Dana R, Sullivan DA, et al. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007; 143:409-415.
2. Rajagopalan K, Abetz L, Mertzanis P, et al. Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye. Value Health. 2005;8:168-174.
3. Schiffman RM, Walt JG, Jacobsen G, et al. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110:1412-1419.
4. Nichols KK. Patient-reported symptoms in dry dye disease. Ocul Surf. 2006;4:137-145.
5. Friedman NJ. Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol. 2010;21:310-316.
6. García-Catalán MR, Jerez-Olivera E, Benítez-Del-Castillo-Sánchez JM. Dry eye and quality of life. Arch Soc Esp Oftalmol. 2009;84:451-458.
7. Mizuno Y, Yamada M, Miyake Y, et al. Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome. Jpn J Ophthalmol. 2010;54:259-265.
8. Li M, Gong L, Chapin WJ, et al. Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci. 2012;53:5722-5727.
9. Mertzanis P, Abetz L, Rajagopalan K, et al. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci. 2005;46:46-50.
10. Buchholz P, Steeds CS, Stern LS, et al. Utility assessment to measure the impact of dry eye disease. Ocul Surf. 2006;4:155-161.
11. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease Index. Arch Ophthalmol. 2000;118:615-621.
12. Abetz L, Rajagopalan K, Mertzanis P, et al. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Outcomes. 2011;9:111.
13. Grubbs JR Jr, Tolleson-Rinehart S, Huynh K, et al. A review of quality of life measures in dry eye questionnaires. Cornea. 2014;33:215-218.
14. McDonald M, D'Aversa G, Perry HD, et al. Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT) therapy with clinical outcomes: Tools for predicting response. Curr Eye Res. 2010;35:880-887.
15. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762-770.
16. Bottomley A, Jones D, Claassens L. Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer. 2009;45:347-353.
17. Reeve BB, Burke LB, Chiang YP, et al. Enhancing measurement in health outcomes research supported by Agencies within the US Department of Health and Human Services. Qual Life Res. 2007;16(suppl 1): 175-186.
18. PROMIS: Instrument Development and Validation Scientific Standards: Version 2.0. May, 2013. Available at: http://www.nihpromis.org/Documents/PROMISStandards-Vers2.0-Final.pdf. Accessed April 25, 2014.
19. Grubbs J. Instrument Development of the UNC Dry Eye Management Scale. Chapel Hill, NC, UNC University Libraries; 2013:1-34. Available at: http://dc.lib.unc.edu/cdm/ref/collection/s-papers/id/2652. Accessed May 1, 2014.
20. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135-160.
21. Chalmers RL, Begley CG, Edrington T, et al. The agreement between self-assessment and clinician assessment of dry eye severity. Cornea. 2005;24:804-810.
22. Guillemin I, Begley C, Chalmers R, et al. Appraisal of patient-reported outcome instruments available for randomized clinical trials in dry eye: revisiting the standards. Ocul Surf. 2012;10:84-99.
23. Taylor R. Interpretation of the correlation coefficient: A basic review. J Diagn Med Sonogr. 1990;1:35-39.